Male Breast Neoplasms (Male Breast Cancer)
200
relevant articles (6 outcomes,
16 trials/studies)
found for this Disease
Description:
Any neoplasms of the male breast. These occur infrequently in males in developed countries, the incidence being about 1% of that in females.
Also Known As:
Male Breast Cancer; Breast Neoplasms, Male; Breast Cancer, Male; Breast Carcinoma, Male; Breast Tumors, Male; Neoplasms, Male Breast; Tumors, Breast, Male; Breast Neoplasm, Male; Breast Tumor, Male; Cancer, Male Breast; Carcinoma, Male Breast; Male Breast Carcinoma; Male Breast Neoplasm; Male Breast Tumor; Male Breast Tumors; Neoplasm, Male Breast; Tumor, Male Breast; Tumors, Male Breast; Neoplasms, Breast, Male
Relationship Network
Disease Context: Research Results
Related Diseases
Experts
| 1. | Brentani, R R:
2 articles
(07/2001 - 07/2001)
|
| 2. | Kurian, K M:
2 articles
(04/2000 - 02/2000)
|
| 3. | Morishita, Y:
2 articles
(01/2001 - 01/2000)
|
| 4. | Cohen, B B:
2 articles
(04/2000 - 02/2000)
|
| 5. | Kunkler, I H:
2 articles
(04/2000 - 02/2000)
|
| 6. | Horiguchi, J:
2 articles
(01/2001 - 01/2000)
|
| 7. | Iino, Y:
2 articles
(01/2001 - 01/2000)
|
| 8. | Kalekou, H:
2 articles
(09/2007 - 07/2005)
|
| 9. | Steel, C M:
2 articles
(04/2000 - 02/2000)
|
| 10. | Carder, P J:
2 articles
(02/2006 - 01/2005)
|
Drugs and Biologics
Drugs and Important Biological Agents (IBA) related to Male Breast Neoplasms:
| 1. | Cyproterone AcetateIBA
|
| 2. | TamoxifenFDA LinkGeneric
|
| 3. | Buserelin (Suprefact)IBA
|
| 4. | anastrozole (Arimidex)FDA Link
|
| 5. | CMF regimenIBA
|
| 6. | HormonesIBA
|
| 7. | Estrogens (Estrogen)FDA Link
|
| 8. | DNA (Deoxyribonucleic Acid)IBA
01/01/1994
- " Studies based on extended materials are necessary to further investigated the role of DNA analysis as a predictor of outcome in male breast cancer patients." 12/01/2004
- " DNA was isolated from male breast cancer biopsies, and the AR CAG repeat sized" 12/15/2003
- " The restoration assays show that AR NH2-terminal/DNA-binding domain, but not the ligand-binding domain, is essential for normal MAPK function in MCF7 cells, and an AR mutant (R608K), found in male breast cancer, is associated with the excessive activation of MAPK" 11/20/2000
- " Nuclear morphometry in male breast carcinoma: association with cell proliferative activity, oncogene expression, DNA content and prognosis." 07/01/1996
- " Quantitative parameters, such as DNA ploidy, p53 scores, AgNOR counts, PC10, and MIB-1 scores substantially improve the prognostic significance of the traditional parameters in male breast carcinoma."
Get all the results and reference details, order at left...
|
| 9. | Progesterone Receptors (Progesterone Receptor)IBA
02/01/1998
- " We report, for the first time, a high frequency of LOH at chromosome 13q12-13 in sporadic male breast cancer and its association with factors indicating a poor prognosis for this tumor (e.g., lymph node metastasis and negative progesterone receptor status)" 05/01/2000
- " The prognostic role of ploidy status, S phase fraction, estrogen and progesterone receptor status, and the expression of p53 and erbB-2 protein in male breast carcinoma (MBC) remains controversial" 11/01/1982
- " Cytoplasmic and nuclear estrogen and progesterone receptors in male breast cancer." 04/01/1980
- " Nine of 14 male breast cancer patients had positive progesterone receptor assays and several had androgen or glucocorticoid receptors" 08/01/2002
- " The aim of this study is to evaluate the expression patterns of estrogen receptor (ER), progesterone receptor (PR), MiB1 (Ki67), Her-2/neu (c-erbB2), and p53 and to correlate them with the prognosis, presentation, staging, management, and survival/outcome in male breast carcinoma identified through the Veterans Administration nationwide cancer registry"
Get all the results and reference details, order at left...
|
| 10. | ParaffinIBA
|
| 98 Drugs and Important Bio-Agents
and
165
more articles analyzed in the Research Interface, order at left...
|
Therapies and Procedures